B44.9
Aspergillosis, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Aspergillosis is an infection caused by the Aspergillus fungus, which is commonly found in the environment, such as in soil, decaying organic matter, and dust. When inhaled, the spores can lead to an infection that primarily affects the lungs but can also spread to other parts of the body. The condition coded as B44.9 in the ICD-10 classification refers to aspergillosis of an unspecified site, meaning the exact location of the infection has not been specified. While some individuals may not experience symptoms, others, especially those with weakened immune systems, can develop serious health issues. Understanding aspergillosis is important for early recognition and management.
Causes & Symptoms
Clinical Causes: Inhalation of airborne spores of the Aspergillus fungus from the environment. Suppressed immune system due to conditions such as leukemia, HIV/AIDS, or organ transplantation. Prolonged use of corticosteroids or other immunosuppressive medications. Existing lung diseases, such as tuberculosis or cystic fibrosis. Pre-existing lung damage that provides a foothold for the fungus.
Key Symptoms: Cough that may produce blood-tinged sputum. Shortness of breath or difficulty breathing. Chest pain or tightness. Fever and chills in some cases. General fatigue and weakness. Wheezing or nasal congestion when sinus involvement occurs. Unexplained weight loss or malaise in severe cases.
Diagnostic & Treatment
Diagnosis Path: Sputum culture to identify the presence of Aspergillus spores. Blood tests to detect specific antibodies or antigens related to the fungus. Biopsy of affected tissue to confirm fungal invasion. Galactomannan test, which detects a component of the Aspergillus cell wall. Serologic tests that support the diagnosis, especially in immunocompromised individuals.
Treatment Protocols: Voriconazole, often considered the first-line therapy. Itraconazole as an alternative or for less severe cases. Amphotericin B in more resistant or severe infections. Surgical intervention in some cases to remove infected tissue or drain abscesses. Adjusting immunosuppressive therapies when possible to improve the immune response.
Clinical Advice & FAQs
Billing Guidance
Is B44.9 a billable ICD-10 code?
Yes, B44.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B44.9?
Clinical documentation must specify the nature of Aspergillosis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference